| dc.contributor.author | Abdulrab, Saleem | |
| dc.contributor.author | Mostafa, Nawras | |
| dc.contributor.author | Al‑Maweri, Sadeq Ali | |
| dc.date.accessioned | 2022-09-27T08:04:33Z | |
| dc.date.available | 2022-09-27T08:04:33Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Abdulrab, S. et al. (2022). Antibacterial and anti‑inflammatory efficacy of n‑acetyl cysteine in endodontic treatment: A scoping review. BMC oral health, 22(1), 398. https://doi.org/10.1186/s12903-022-02433-6 | en_US |
| dc.identifier.issn | 1472-6831 | |
| dc.identifier.uri | https://doi.org/10.1186/s12903-022-02433-6 | |
| dc.identifier.uri | http://hdl.handle.net/10566/7964 | |
| dc.description.abstract | This scoping review systematically summarized the available evidence about the efficacy of N-acetyl
cysteine (NAC) as an intracanal antibacterial and/or anti-inflammatory.PubMed, Scopus, Web of Science, and Google scholar search engines/databases were searched up to
February 2022 to retrieve relevant studies. The studies were evaluated for eligibility criteria, and identifying relevant
studies.Out of 193 studies, 15 fulfilled the inclusion criteria and were processed for data extraction. Thirteen in vitro
studies assessed antibacterial/antibiofilm efficacy of NAC, and reported good and promising efficacy: NAC was found
as efficacious as the comparators (chlorhexidine, sodium hypochlorite, calcium hydroxide), or even showed higher
efficacy. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BMC | en_US |
| dc.subject | N-acetyl cysteine | en_US |
| dc.subject | Oral health | en_US |
| dc.subject | Endodontic | en_US |
| dc.subject | Root canal disinfection | en_US |
| dc.title | Antibacterial and anti‑inflammatory efficacy of n‑acetyl cysteine in endodontic treatment: A scoping review | en_US |
| dc.type | Article | en_US |
